Piramal Pharma Limited — Diltiazem Exporter Profile
Indian Pharmaceutical Exporter · #3 for Diltiazem · $1.9M export value · DGFT Verified
Piramal Pharma Limited is the #3 Indian exporter of Diltiazem with $1.9M in export value and 37 verified shipments. Piramal Pharma Limited holds a 10.3% market share in Diltiazem exports across 2 countries. The company exports 8 pharmaceutical products worth $64.5M across 5 therapeutic categories.
Piramal Pharma Limited — Diltiazem Export Profile: Buyers & Destinations
Where Does Piramal Pharma Limited Export Diltiazem?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.4M | 36 | 100.0% |
| CROATIA | $8 | 1 | 0.0% |
Piramal Pharma Limited exports Diltiazem to 2 countries. The largest destination is UNITED STATES accounting for 100.0% of Piramal Pharma Limited's Diltiazem shipments. These destinations reflect Piramal Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Diltiazem from Piramal Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TEVA PHARMACEUTICALS USA, INC | UNITED STATES | $1.1M | 27 |
| TEVA PHARMACEUTICALS USA INC | UNITED STATES | $326.0K | 9 |
| MATEA KOVACIC PLIVA HRVATSKA PRILAZ | CROATIA | $8 | 1 |
Piramal Pharma Limited supplies Diltiazem to 3 buyers globally. The largest buyer is TEVA PHARMACEUTICALS USA, INC (UNITED STATES), followed by TEVA PHARMACEUTICALS USA INC (UNITED STATES) and MATEA KOVACIC PLIVA HRVATSKA PRILAZ (CROATIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Diltiazem Export Value and How Much Does Piramal Pharma Limited Contribute?
India exported $14.4M worth of Diltiazem through 1,820 shipments from 184 suppliers to 71 countries, serving 298 buyers globally. Piramal Pharma Limited contributes $1.9M to this total, accounting for 10.3% of India's Diltiazem exports. Piramal Pharma Limited ships Diltiazem to 2 countries through 3 buyers.
What Is the Average Shipment Value for Piramal Pharma Limited's Diltiazem Exports?
Piramal Pharma Limited's average Diltiazem shipment value is $50.0K per consignment, based on 37 shipments totaling $1.9M. The largest destination is UNITED STATES (100.0% of Piramal Pharma Limited's Diltiazem exports).
How Does Piramal Pharma Limited Compare to Other Indian Diltiazem Exporters?
Piramal Pharma Limited ranks #3 among 184 Indian Diltiazem exporters with a 10.3% market share. The top 3 exporters are EMCURE PHARMACEUTICALS LIMITED ($3.2M), MAIVA PHARMA PRIVATE LIMITED ($2.3M), PIRAMAL PHARMA LIMITED ($1.9M). Piramal Pharma Limited processed 37 shipments to 2 destination countries.
What Diltiazem Formulations Does Piramal Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| (400825001) DILTIAZEM HCL TABLETS 30MG 1 | $150.0K | 3 |
| "(400825006) DILTIAZEM HCL TABLETS 120MG100 (QUANTITY : 37,104.000 ECH ) | $100.0K | 2 |
| 400825002 DILTIAZEM HCL TABLETS 30MG 500s Quantity 5 899 000 ECH | $94.3K | 3 |
| (400825002) DILTIAZEM HCL TABLETS 30MG 5 | $67.0K | 2 |
| (400825003) DILTIAZEM HCL TABLETS 60 MG100 (QUANTITY : 14,592.000 ECH ) | $61.5K | 2 |
| (400825004) DILTIAZEM HCL TABLETS 60MG 5 | $53.3K | 2 |
| (400825005) DILTIAZEM HCL TABLETS 90MG 1 | $50.0K | 1 |
| (400825003) DILTIAZEM HCL TABLETS 60 MG | $50.0K | 1 |
| 400825001 DILTIAZEM HCL TABLETS 30MG 100s Quantity 58 392 000 ECH | $50.0K | 1 |
| 400825006 DILTIAZEM HCL TABLETS 120MG | $50.0K | 1 |
Piramal Pharma Limited exports 29 distinct Diltiazem formulations including tablets, capsules, syrups, and combination drugs. The top formulation is (400825001) DILTIAZEM HCL TABLETS 30MG 1 with 3 shipments worth $150.0K.
Regulatory Requirements: Exporting Diltiazem to Key Markets
What Piramal Pharma Limited must comply with to export Diltiazem to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Piramal Pharma Limited Compare to Nearest Diltiazem Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | EMCURE PHARMACEUTICALS LIMITED | $3.2M | 130 | 3 | $24.9K |
| 2 | MAIVA PHARMA PRIVATE LIMITED | $2.3M | 47 | 1 | $49.3K |
| 3 | PIRAMAL PHARMA LIMITED ★ | $1.9M | 37 | 2 | $50.0K |
| 4 | INTAS PHARMACEUTICALS LIMITED | $1.3M | 26 | 1 | $50.0K |
| 5 | MYLAN LABORATORIES LIMITED | $1.2M | 29 | 1 | $43.1K |
Piramal Pharma Limited ranks #3 among 184 Indian Diltiazem exporters. Average shipment value of $50.0K compared to the market average of $78.0K. The closest competitors by value are EMCURE PHARMACEUTICALS LIMITED and MAIVA PHARMA PRIVATE LIMITED.
Which Indian Ports Ship Diltiazem Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 357 | 19.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 302 | 16.6% |
| DELHI AIR CARGO ACC (INDEL4) | 201 | 11.0% |
| NHAVA SHEVA SEA (INNSA1) | 181 | 9.9% |
| DELHI AIR | 155 | 8.5% |
| Bombay Air | 100 | 5.5% |
| JNPT/ NHAVA SHEVA SEA | 52 | 2.9% |
| Delhi Air | 36 | 2.0% |
What Other Cardiovascular Products Does Piramal Pharma Limited Export?
Piramal Pharma Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Piramal Pharma Limited's Diltiazem Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like PPL. The Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to impose 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts the profitability of exports to Europe and the U.S. East Coast, necessitating strategic adjustments in logistics and pricing strategies. (sgexports.odoo.com)
Simultaneously, the 2025 United States–India diplomatic and trade crisis has introduced additional complexities. The U.S. administration's imposition of a 50% tariff on Indian exports, in response to India's energy policies, has significantly affected trade dynamics. This development compels companies like PPL to reassess their market strategies and explore alternative markets to mitigate the impact of these tariffs. (en.wikipedia.org)
On a positive note, the European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) has prompted the Directorate General of Foreign Trade (DGFT) in India to establish a 'CBAM Facilitation Cell.' This initiative aims to assist exporters in complying with new environmental regulations, potentially providing PPL with a competitive edge in the EU market by aligning with sustainability standards. (sgexports.odoo.com)
Piramal Pharma Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for pharmaceutical exporters. PPL's Turbhe facility in Maharashtra underwent a U.S. FDA inspection in February 2025, resulting in a Form 483 with six observations. The company addressed these concerns, leading to the issuance of an Establishment Inspection Report (EIR) with a classification of Voluntary Action Indicated (VAI) in May 2025, signifying successful closure of the inspection. (business-standard.com)
Similarly, the Riverview facility in the U.S. received an EIR in April 2024, following a pre-approval inspection that concluded with three observations classified under VAI. These developments reflect PPL's proactive approach to regulatory compliance and its commitment to upholding global quality standards. (business-standard.com)
About Piramal Pharma Limited
Piramal Pharma Limited exports 8 products worth $64.5M. Beyond Diltiazem, top products include Atorvastatin, Calcium, Ezetimibe, Carvedilol, Iron. View the complete Piramal Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Diltiazem — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Diltiazem shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Piramal Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 37 individual customs records matching Piramal Pharma Limited exporting Diltiazem, covering 29 formulations to 2 countries via 3 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 71+ countries, 298+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Diltiazem Export Data from Piramal Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Piramal Pharma Limited's Diltiazem exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Piramal Pharma Limited
Full Company Profile →
8 products · $64.5M total trade · 5 categories
Diltiazem Stats
Company Overview
Top Products by Piramal Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Piramal Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Diltiazem. For current shipment-level data, contact TransData Nexus.